Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2010

01-01-2010 | Case Report

An unusual case of autoimmune hepatitis in a patient with adult-onset Still’s disease

Authors: Li-Xin Xia, Ting Xiao

Published in: Clinical Rheumatology | Issue 1/2010

Login to get access

Abstract

Adult-onset Still's disease (AOSD) is an autoimmune disease characterized by spiking fever, evanescent rash, arthritis, serositis, and liver involvement. Although autoimmune hepatitis (AIH) has been reported in association with various autoimmune diseases, AOSD-associated AIH is rare. We herein report an unusual case of AIH in a patient with AOSD.
Literature
1.
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed
2.
Khaled A, Fazaa B, Mrabet N, Zeglaoui F, Kamoun MR (2008) Multiple autoimmune syndrome in a patient with pemphigus vulgaris: a new combination. Tunis Med 86:595–597PubMed
3.
Gurudu SR, Mittal SK, Shaber M, Gamboa E, Michael S, Sigal LH (2000) Autoimmune hepatitis associated with autoimmune hemolytic anemia and anticardiolipin antibody syndrome. Dig Dis Sci 45:1878–1880CrossRefPubMed
4.
Marie I, Levesque H, Tranvouez JL, Francois A, Riachi G, Cailleux N, Courtois H (2001) Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology 40:102–106CrossRefPubMed
5.
Maclachlan D, Tyndall A (2000) Acute hepatitis in adult Still's disease apparently resulting from oral iron substitution-a case report. Clin Rheumatol 19:222–225CrossRefPubMed
6.
Jung JH, Jun JB, Yoo DH, Kim TH, Jung SS, Lee IH, Bae SC, Kim SY (2000) High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol 18:245–248PubMed
7.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938CrossRefPubMed
8.
Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY (2004) Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2:625–631CrossRefPubMed
9.
Min JK, Han NI, Kim JA, Lee YS, Cho CS, Kim HY (2001) A case of cholestatic autoimmune hepatitis and acute liver failure: an unusual hepatic manifestation of mixed connective tissue disease and Sjogren’s syndrome. J Korean Med Sci 16:512–515PubMed
10.
Redondo-Cerezo E, Nogueras-Lopez F, Martin-Vivaldi R, Simon EE (2002) Fulminant hepatic failure as the presenting form of type 1 autoimmune hepatitis in the elderly. Am J Gastroenterol 97:1265–1266CrossRefPubMed
11.
Kawai K, Michitaka K, Miyauchi S, Sano M, Abe M, Ninomiya T, Matsuura B, Masumoto T, Akbar SM, Horiike N, Onji M (2003) Acute-onset autoimmune hepatitis treated with living donor-liver transplantation. Intern Med 42:158–162CrossRefPubMed
12.
Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM, US Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954PubMed
Metadata
Title
An unusual case of autoimmune hepatitis in a patient with adult-onset Still’s disease
Authors
Li-Xin Xia
Ting Xiao
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1186-z

Other articles of this Issue 1/2010

Clinical Rheumatology 1/2010 Go to the issue

Original Article

Back pain amongst 8,910 young Australian women: a longitudinal analysis of the use of conventional providers, complementary and alternative medicine (CAM) practitioners and self-prescribed CAM

Case Report

Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva

Case Report

Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

Review Article

Non-Hodgkin’s lymphoma in systemic sclerosis: case and literature review

Case Report

Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis

Original Article

Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits